Statements (34)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Riad_Armanious
|
| gptkbp:country |
gptkb:Egypt
|
| gptkbp:exportedTo |
over 40 countries
|
| gptkbp:focusArea |
gptkb:diabetes
antibiotics oncology pain management central nervous system cardiovascular diseases respiratory diseases gastrointestinal diseases vitamins and supplements |
| gptkbp:foundedIn |
1997
|
| gptkbp:headquartersLocation |
gptkb:Cairo
|
| https://www.w3.org/2000/01/rdf-schema#label |
Eva Pharma
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:languageOfService |
gptkb:Arabic
English |
| gptkbp:manufacturingFacilities |
gptkb:Egypt
gptkb:Germany |
| gptkbp:market |
gptkb:Africa
gptkb:Europe gptkb:Middle_East |
| gptkbp:notableProduct |
gptkb:Favipiravir
gptkb:Remdesivir |
| gptkbp:numberOfEmployees |
over 3500
|
| gptkbp:parentCompany |
gptkb:Armanious_Group
|
| gptkbp:products |
branded medicines
generic medicines |
| gptkbp:type |
gptkb:public_company
|
| gptkbp:website |
https://www.evapharma.com/
|
| gptkbp:bfsParent |
gptkb:6th_of_October_Industrial_Zone
|
| gptkbp:bfsLayer |
6
|